Founding in the #DeepTech sector: your chance to change the world! 🤯 🌈 🤬 🤩 😭 - Founding a Deep-Tech start-up is an emotional rollercoaster. Your idea could revolutionize technology, but with every advance, the questions and uncertainties grow. Start-ups in the field of key technologies make an enormous contribution to the economy and climate, but they often face huge #challenges such as: 🔹 Long development times 🔹 High capital requirements 🔹 Lack of mentors, partners and investors 🔹 Difficult access to customers, infrastructure and political support And you ask yourself: How do I find the right capital? How do I plan production? How do I overcome hurdles in collaborations and present myself convincingly? HIGH-TECH.NRW can help you with this! ☝️ Until January 31, 2025, we are looking for visionary start-ups in areas such as: 🔹 New materials 🔹 Nanotechnology 🔹 Microsystems technology 🔹 Photonics 🔹 Quantum technology 🔹 Industrial tech 🔹 Nano & microelectronics🔹 Climate tech 🔹 Medtech Our team (Heinz, Oliver, Kirsten) will provide you with feedback and support on why participating in the program could be worthwhile. 🚀 Or apply directly without detours: 👉 https://lnkd.in/ea28scnV Ministerium für Wirtschaft, Industrie, Klimaschutz und Energie des Landes NRW NMWP Management GmbH Norbert von Thienen Dr.-Ing. Harald Cremer Hendrik Köster Daniel Stadler
HIGH-TECH.NRW’s Post
More Relevant Posts
-
#deeptech is revolutionizing industries with advanced technologies that tackle some of the world's most complex problems. This exciting field encompasses several key categories: 🔬 Biotech: Innovations in healthcare, agriculture, and environmental sustainability. 🤖 AI & Robotics: Cutting-edge developments in artificial intelligence, machine learning, and automation. 💡 Quantum Computing: Breakthroughs in computational power and problem-solving capabilities. ⚛️ Advanced Materials: Creation of new materials with unique properties for various applications. 🔋 Energy Tech: Sustainable energy solutions and innovations in energy storage and efficiency. And the opportunities are vast: 🌍 Global Impact: DeepTech solutions have the potential to address critical global issues like climate change, healthcare, and food security. 💼 Market Potential: With the right support, DeepTech startups can capture substantial market share and drive economic growth. 🤝 Collaborative Innovation: Partnerships between startups, corporates, and research institutions can accelerate development and deployment. ‼️ Learn more about how we foster partnerships between startups, corporates and research institutes here: https://lnkd.in/dkT8S_ck At MotionLab.Berlin, and as the newly appointed DeepTech Hub Berlin for Deep Tech Berlin we are proud to support DeepTech innovators as they push the boundaries of what's possible. For example: ➡ Advanced Materials: MotorSkins is leading the way. ➡ Nanotechnology: NanoMatter is making strides in semiconductor manufacturing. ➡ Robotics and Automation: Driven by startups like Bearcover and Skycharge. ➡ Energy Technologies: Innovations like green energy storage from LIQUIDLOOP and direct air capture from Ucaneo ➡ Advanced sensor technology within spacetech such as that solution of AIRMO Senatsverwaltung für Wirtschaft, Energie und Betriebe, Berlin.Industrial.Group. (B.I.G.), Venture Lab Niterra Group, Lemberg Solutions, Würth Elektronik Group, RCKT., Germany Trade & Invest, Digital Hub Initiative #DeepTech #Innovation #Biotech #AI #QuantumComputing #AdvancedMaterials #EnergyTech #Startups #Sustainability #MotionLabBerlin #netzero
To view or add a comment, sign in
-
🚀 Exciting developments in the tech world! Lightmatter, a pioneer in silicon photonics, has just secured a staggering $400 million in Series D funding, propelling its valuation to $4.4 billion. This surge nearly quadruples its prior valuation of $1.2 billion from December 2022! Why is this important? 🤔 As AI continues to drive massive investments in data centers, Lightmatter is addressing critical challenges in energy consumption and scalability with its innovative technology. By utilizing light for computation, they not only enhance processing speeds but also significantly reduce power requirements—an essential step in sustainable tech development. In just six years since its inception, Lightmatter has raised a total of $850 million, showcasing the growing confidence investors have in their vision. Co-founder and CEO Nick Harris mentioned that this could be their last round of private funding, hinting at future aspirations for an IPO! The momentum doesn't stop there! Another photonic startup, Xscape Photonics, has also made headlines with a $44 million Series A funding to tackle similar challenges for AI data centers. As these developments unfold, it's clear that the future of computing is becoming increasingly efficient and environmentally friendly. Let’s keep an eye on these trailblazers in the photonics arena! For more insights, check the original article here: https://lnkd.in/dfkADYRz
To view or add a comment, sign in
-
BIG NEWS: Introducing Lux Labs 🧪🔬 Brilliant scientists + proven ideas + freedom to build = turning sci-fi into sci-fact For too long, we've watched ideas get stuck in the limbo between research labs and the real world. Whether it's university IP red tape, corporate bureaucracy, or the challenge of building the right team - great innovations often stay trapped in the lab. Lux Labs is our way of giving transformative ideas the entrepreneurial scaffolding they need to thrive: ⚡ Navigating IP rights and incorporation ⚡ Strategic funding from seed to scale ⚡ Access to elite technical networks ⚡ Startup guidance from battle-tested experts We're formalizing what we've already done with 20+ successful companies including: 💡 Aeva (next-gen autonomous sensing) 💡 EvolutionaryScale (gen AI for bio) 💡 Kurion (nuclear waste cleanup) 💡 Osmo (digitizing scent via AI/ML) 💡 Variant Bio (genome based drug discovery) While we'll continue our traditional venture investing ($100K-$100M checks), Lux Labs doubles down on our commitment to turn the impossible into the inevitable. Let's build the future 🚀 More 👇 on how we're creating & building companies from scratch READ 📕 https://lnkd.in/eTcNUNHU WATCH 📺 https://lnkd.in/eteeT2vd
To view or add a comment, sign in
-
Universities and research institutes are rich sources of innovation, yet far too often, promising research doesn’t make it beyond the lab. This is where #TechnologyTransfer becomes crucial: translating cutting-edge research into impactful, market-ready solutions. In my experience working at the intersection of deep tech startups and corporations, building partnerships has been critical in transforming ideas into tangible impact. But how can we create a culture that fosters deep collaboration and accelerate the journey from lab to marketplace? As we navigate the complexities of technology transfer, it’s essential to recognise the broader opportunities, while also addressing the challenges of incentive alignment and support for innovation. How can we better incentivise academics and business professionals to move beyond the boundaries of academia and drive real-world impact? And how can we balance curiosity-driven research with commercial opportunities? The innovation landscape is filled with opportunities, despite challenges like supply chain disruptions and geopolitical tensions. Emerging fields like #AI, #QuantumComputing, and #GreenTech are driving change, with global R&D spending hitting record levels in 2022. Ultimately, the goal is to create a dynamic ecosystem where collaboration across sectors leads to greater innovation and sustainable progress. Kudos to Marco M. Alemán, Alejandro Roca Campana, Lien VERBAUWHEDE KOGLIN, Suma Athreye, Andrea Basso, Tom Hockaday, Abhijit Sengupta, Olga Spasic, Claudia Chiavarino, Mattias Karlsson Dinnetz, and Olga Kusanova for the guide: Incentives in Technology Transfer. “This Guide is a rare combination of deep analysis of complex issues in technology transfer and very practical tips and tools. I highly recommend it to any leader or practitioner in tech transfer, as well as policy makers and university leadership." Gil Granot-Mayer, Okinawa Institute of Science and Technology Read more here: https://lnkd.in/dkHG6TNW
To view or add a comment, sign in
-
Why Aren't More Researchers Commercialising Their Work? 🤔 As I spend more time in the amazing world of commercialisation, I keep wondering: why aren’t more researchers (both scientists and clinicians) getting their discoveries out into the real world? It seems wild, especially when so many of us got into research to make a real impact! I initially thought the problem might be the language barrier—the way we talk about our work in research can be so different from the way things are discussed in commercialisation. It can feel like a steep mountain to climb, especially when you're suddenly dealing with a whole new set of stakeholders (a word I never thought I'd use so much!). But lately, I’ve realised it’s more than just language. It’s a fundamental misunderstanding of what each group in the commercialisation ecosystem actually wants or needs to do. For example, if a venture capitalist (VC) doesn’t want to back your project, it might not mean they don’t see the value. It could simply be that your research doesn’t align with their fund’s specific goals or growth targets. Or maybe they need you to hit a certain milestone first. Understanding these different priorities can help researchers plan projects that align better and create stronger impact pathways. So, here’s my take on the key interests of four major players in the commercialisation journey. I'd love to hear your thoughts! Is there anything you'd add? Or something you think the rest of the ecosystem should understand about your perspective? 🔬 Researchers: You often align your work with funding bodies or government priorities, but are you considering the needs of clinicians or VCs? 🏥 Clinicians: Your main goal is clear—helping patients feel better. But do researchers really understand your pain points in the field? 💡 Tech Transfer Offices: You want to help researchers create more impact, but you need them to engage early to make commercialisation possible. 💸 VCs: You’re also in it to help people, but financial return is crucial. Do researchers understand what you’re looking to invest in and why? Let’s bridge the gap and work together to bring more groundbreaking research into the real world! 🌍💡 ----- Kia ora! 👋 I'm Maddie White, PhD Click my name, follow or connect to stay updated! I'm a scientist on a mission to drive innovation by building connections and facilitating partnerships that transform groundbreaking research into real-world impact. I'm passionate about creating networks that empower scientists, opening doors for PhD graduates, and bringing top talent back to Aotearoa New Zealand. Like this post? Show some love! Like 👍 | Comment ✍ | Repost ♻ #Innovation #Science #ResearchImpact #Commercialisation #Networking #PhDCareers #Aotearoa #NewZealand #STEM #TalentDevelopment #Partnerships #ResearchCommercialisation #CareerGrowth
To view or add a comment, sign in
-
There is also a gap in the understanding of the importance of protecting IP. If the technology isn't protected, why would an investor put money in when they can't control who can use it? Medical research outputs (pharmaceuticals and med tech devices) are so very expensive to get approval for, why invest if it can be copied?
Why Aren't More Researchers Commercialising Their Work? 🤔 As I spend more time in the amazing world of commercialisation, I keep wondering: why aren’t more researchers (both scientists and clinicians) getting their discoveries out into the real world? It seems wild, especially when so many of us got into research to make a real impact! I initially thought the problem might be the language barrier—the way we talk about our work in research can be so different from the way things are discussed in commercialisation. It can feel like a steep mountain to climb, especially when you're suddenly dealing with a whole new set of stakeholders (a word I never thought I'd use so much!). But lately, I’ve realised it’s more than just language. It’s a fundamental misunderstanding of what each group in the commercialisation ecosystem actually wants or needs to do. For example, if a venture capitalist (VC) doesn’t want to back your project, it might not mean they don’t see the value. It could simply be that your research doesn’t align with their fund’s specific goals or growth targets. Or maybe they need you to hit a certain milestone first. Understanding these different priorities can help researchers plan projects that align better and create stronger impact pathways. So, here’s my take on the key interests of four major players in the commercialisation journey. I'd love to hear your thoughts! Is there anything you'd add? Or something you think the rest of the ecosystem should understand about your perspective? 🔬 Researchers: You often align your work with funding bodies or government priorities, but are you considering the needs of clinicians or VCs? 🏥 Clinicians: Your main goal is clear—helping patients feel better. But do researchers really understand your pain points in the field? 💡 Tech Transfer Offices: You want to help researchers create more impact, but you need them to engage early to make commercialisation possible. 💸 VCs: You’re also in it to help people, but financial return is crucial. Do researchers understand what you’re looking to invest in and why? Let’s bridge the gap and work together to bring more groundbreaking research into the real world! 🌍💡 ----- Kia ora! 👋 I'm Maddie White, PhD Click my name, follow or connect to stay updated! I'm a scientist on a mission to drive innovation by building connections and facilitating partnerships that transform groundbreaking research into real-world impact. I'm passionate about creating networks that empower scientists, opening doors for PhD graduates, and bringing top talent back to Aotearoa New Zealand. Like this post? Show some love! Like 👍 | Comment ✍ | Repost ♻ #Innovation #Science #ResearchImpact #Commercialisation #Networking #PhDCareers #Aotearoa #NewZealand #STEM #TalentDevelopment #Partnerships #ResearchCommercialisation #CareerGrowth
To view or add a comment, sign in
-
🌐 Deeptech Startups: Revolutionizing the Future 🚀 In recent years, the Deeptech sector has been transforming industries with cutting-edge innovations and creating disruptive solutions to complex global challenges. Unlike traditional startups, deeptech ventures are focused on scientific advancements and high-tech innovations—from AI, quantum computing, and nanotechnology to biotech and robotics. Here are some emerging trends in the Deeptech ecosystem: AI-Driven Solutions 🤖: AI continues to dominate, enabling startups to solve previously unsolvable problems—from personalized healthcare to autonomous systems. Quantum Computing 💻: With quantum capabilities advancing, startups are pushing the boundaries of data processing and encryption, paving the way for faster and more secure technologies. Sustainability & Green Tech 🌱: Deeptech is at the forefront of sustainable innovations, focusing on clean energy, climate tech, and waste reduction solutions. Biotech Breakthroughs 🧬: From personalized medicine to gene editing, biotech startups are revolutionizing healthcare with technologies like CRISPR and advanced diagnostics. Space Tech 🚀: With declining launch costs and advancements in satellite technology, startups are exploring space commercialization, from satellite networks to asteroid mining. Investors are increasingly drawn to Deeptech startups due to their potential for long-term impact and value creation. Although they require more time and resources to develop, the scalability and societal benefits make them highly promising. 💡 As we move towards a tech-driven future, deeptech innovations are set to redefine industries and unlock new opportunities for growth. Exciting times ahead for startups and investors in this space! 🌟 #DeepTech #Innovation #Startups #AI #QuantumComputing #Sustainability #Biotech #FutureTech #InvestingInInnovation #TechTrends
To view or add a comment, sign in
-
atTRACTION: Connecting Deep-Tech Innovation Ecosystems is looking for deep-tech startups, university spin-offs, and research teams of scientists to solve several projects, as requested by corporations, businesses and other parties from various sectors. The benefits you get are a chance to gain a major customer, industry exposure, access to resources and funding opportunities. The challenges are the following: 1️⃣ Hybrid fluid aspiration and delivery device; 2️⃣ Colored dual-purpose low-dose exposure indicators; 3️⃣ Wastewater blower optimization control; 4️⃣ Integrated sewage flow management to prevent overflows in pumping station networks; 5️⃣ Optimizing self-taken medical imaging by creating an algorithm for accurate photo evaluation; 6️⃣ Developing a mobile app for real-time post-operative rehabilitation monitoring and personalized recovery after joint replacement surgeries; 7️⃣ Development of mobile tools for pre-and post-operative stimulation and monitoring of abdominal wall and respiratory muscles; 8️⃣ Energy storage devices and technologies for 0-10MW; 9️⃣ Solar park generation forecasting tools to balance the electricity system in advance. ☝ Today is the last day to apply, thus if you have an idea or a solution, please submit your proposal at this link: https://lnkd.in/dK3ZvvTU
To view or add a comment, sign in
-
Delighted for the opportunity to give a presentation about Cambridge Tech last week at Founders at the University of Cambridge's Demo Day in at Kings Place in London. Huge thanks to Gerard Grech for making this happen. A link to the PDF and some other data will follow in the comments. Some takeaways: 🧬 Cambridge ranks third globally, following Boston, in terms of output per capita in scientific and engineering breakthroughs making their way to making their way into products and companies 📈 Cambridge represents 18% of UK's tech value, with only 3% of the input! It produces over $16.9 in value for every dollar of VC investment. A testament to the potential when academia, entrepeneurship and venture capital converge 🧪 Cambridge is the #1 university in Europe for producing spinouts, showcasing its robust pipeline of innovation Great to see these findings got covered by BBC News TV, City AM, and others. Curious about Cohort 1.0? AetoSense – applying patented technology to drive precision in air quality monitoring, addressing potential health hazards BioTryp Therapeutics – dividing bacteria to conquer infections and provide an alternative to traditional antibiotics, starting with urinary tract infections BravelyCultured – using a proprietary marine microbial biobank and solid-state cultivation methods to replace animal- and petroleum-based products Cambridge Vision Technology – early detection of Alzheimer’s Molyon – creating next generation high-energy density batteries for weight-critical applications Nanomation – building computer vision software for the semiconductor industry to enable clients to build products using advanced, complex nanomaterials Orbit – using non-invasive nanotechnology to create a smart fitness device for brains, making mental health data transparent and actionable Protonera – turning waste plastics into valuable commodities to make recycling work VOLTQUANT – fixing the UK electricity grid to solve one of the biggest challenges preventing Net Zero William Oak – developing a point-of-care test for micronutrient deficiencies to improve maternal, infant and child health Xterna – engineering a cell-targeting platform that delivers therapeutic cargo to specific cell types cc Dealroom.co, Orla Browne, Serena Connor
To view or add a comment, sign in
-
Sharing our investment team's Deep Tech whitepaper – a must-read for those navigating the dynamic landscape of Deep Tech innovation. Deep tech spans many technological areas, including: AI, Augmented Reality, quantum computing, advanced sensing and perception, photonics, robotics, and semiconductors. As a result, deep tech encompasses highly investable sectors like smart devices and the metaverse, digital health, medical devices and MedTech, autonomous systems and vehicles, and energy efficiency. However, the development of deep tech technology typically requires longer development cycles, greater capital requirements at the outset, and companies potentially face emerging, uncertain or underdeveloped markets. Consequently, deep tech will often be considered a “riskier” investment. With a well-considered IP strategy, companies can attract crucial investments and secure their place in the market. This whitepaper is designed to inform investors based on our experience and expertise, but also serves as a valuable resource for deep tech companies by providing insights, including on what investors look for and how the right IP strategy can protect deep tech innovations and restrict competitors from entering your company's chosen market. From the protecting the tech side, my patent attorney colleagues Dave Clark, Ben Lincoln, and I have a wealth of material for innovators operating in this space so it if this raises any questions, please do get in touch if you would like anything further. #VerifyiP #Deeptech
To view or add a comment, sign in
2,184 followers
Public funding and infrastructure for startups and sme (SME) in Northrhine-Westfalia - consulting, seminars, workshops
3woutstanding network and service. Definitely worth applying for it💚